Neue Medikamente in der Glaukomtherapie = New drugs in glaucomaGROMER, E.Klinische Monatsblätter für Augenheilkunde. 1998, Vol 213, Num 1, pp aA10-aA12, issn 0023-2165Article

The effect of 1% apraclonidine on visual field parameters in patients with glaucoma and ocular hypertensionMASTROPASQUA, L; CIANCAGLINI, M; CARPINETO, P et al.Annals of ophthalmology. Glaucoma. 1998, Vol 30, Num 1, pp 41-45, issn 1079-4794Article

Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patientsKOC, Feray; KANSU, Tulay; KAVUNCU, Sevim et al.Journal of neuro-ophthalmology. 2006, Vol 26, Num 1, pp 25-29, issn 1070-8022, 5 p.Article

The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidineLEWIS, R; PERKINS, T. W; GANGNON, R et al.Ophthalmology (Rochester, MN). 1998, Vol 105, Num 12, pp 2256-2259, issn 0161-6420Article

Central α-2 Adrenergic Eye Drops : Case Series of 3 Pediatric Systemic PoisoningsRANGAN, Cyrus; EVERSON, Gary; CANTRELL, F. Lee et al.Pediatric emergency care. 2008, Vol 24, Num 3, pp 167-169, issn 0749-5161, 3 p.Article

Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomyÜNAL, Mustafa; YÜCEL, Iclal; AKAR, Yusuf et al.Journal of cataract and refractive surgery. 2006, Vol 32, Num 9, pp 1499-1502, issn 0886-3350, 4 p.Article

The effect of topical apraclonidine on subconjunctival hemorrhage and flap adherence in LASIK patientsASLANIDES, Ioannis M; TSIKLIS, Nikolaos S; OZKILIC, Efekan et al.Journal of refractive surgery (1995). 2006, Vol 22, Num 6, pp 585-588, issn 1081-597X, 4 p.Article

Clonidine provides an allergy-free alternative in glaucoma patients with proven allergy to apraclonidineGEYER, O; SCHMIDT, K. G; PIANKA, P et al.Graefe's archive for clinical and experimental ophthalmology. 2000, Vol 238, Num 2, pp 149-152, issn 0721-832XArticle

Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser proceduresCHEVRIER, R. L; ASSALIAN, A; DUPERRE, J et al.Ophthalmic surgery and lasers. 1999, Vol 30, Num 3, pp 199-204, issn 1082-3069Conference Paper

Comparison of the early effects of Brimonidine and apraclonidine as topical ocular hypotensive agentsMAUS, T. L; NAU, C; BRUBAKER, R. F et al.Archives of ophthalmology (1960). 1999, Vol 117, Num 5, pp 586-591, issn 0003-9950Article

Long-term brimonidine therapy in glaucoma patients with apraclonidine allergySHIN, D. H; GLOVER, B. K; CHA, S. C et al.American journal of ophthalmology. 1999, Vol 127, Num 5, pp 511-515, issn 0002-9394Article

New agents in glaucoma therapyKOONER, K. S.International ophthalmology clinics. 1999, Vol 39, Num 3, pp 1-15, issn 0020-8167Article

The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomySIMSEK, S; ERTÜRK, H; DEMIROK, A et al.European journal of ophtalmology. 1998, Vol 8, Num 3, pp 167-172, issn 1120-6721Article

The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresisKOC, F; KAVUNCU, S; KANSU, T et al.British journal of ophthalmology. 2005, Vol 89, Num 11, pp 1442-1444, issn 0007-1161, 3 p.Article

Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgeryCHEN, Teresa C.Journal of cataract and refractive surgery. 2005, Vol 31, Num 9, pp 1707-1712, issn 0886-3350, 6 p.Article

Comparison of the efficacy of Apraclonidine and brimonidine as aqueous suppressants in humansSCHADLU, R; MAUS, T. L; NAU, C. B et al.Archives of ophthalmology (1960). 1998, Vol 116, Num 11, pp 1441-1444, issn 0003-9950Article

Apraclonidine : en périchirurgie oculaire = Apraclonidine : in ocular surgeryLa Revue Prescrire. 1998, Vol 18, Num 180, pp 14-17, issn 0247-7750Article

Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikesCHUNG, H. S; SHIN, D. H; BIRT, C. M et al.Ophthalmology (Rochester, MN). 1997, Vol 104, Num 11, pp 1921-1925, issn 0161-6420Conference Paper

Allergic contact dermatitis from apraclonidine in eyedropsSILVESTRE, J. F; CARNERO, L; RAMON, R et al.Contact dermatitis. 2001, Vol 45, Num 4, issn 0105-1873, p. 251Article

Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplastyJIANMING REN; SHIN, D. H; CHUNG, H. S et al.Ophthalmology (Rochester, MN). 1999, Vol 106, Num 6, pp 1135-1139, issn 0161-6420Article

The short-term effects of topical 1% apraclonidine on macular blood flowGROSSMAN, H; BROWN, G. C; CATER, J. R et al.Annals of ophthalmology. Glaucoma. 1998, Vol 30, Num 3, pp 150-153, issn 1079-4794Article

Prophylactic use of apraclonidine for intraocular pressure increase after 180-degree argon laser trabeculoplastySAGDIC YALVAC, I; EKSIOGLU, Ü; KARAGÖZ, Y et al.Annals of ophthalmology. Glaucoma. 1996, Vol 28, Num 4, pp 240-243, issn 1079-4794Article

Evaluation of adverse reactions of aponidine hydrochloride ophthalmic solutionLIN, S. L; LIANG, S. S.Journal of ocular pharmacology and therapeutics. 1995, Vol 11, Num 3, pp 267-278, issn 1080-7683Conference Paper

Confirmation of Horner's syndrome using apraclonidine eye dropsCHU, Colin J; FERRIS, John D.Postgraduate medical journal. 2011, Vol 87, Num 1028, issn 0032-5473, p. 440Article

The use of apraclonidine in the diagnosis of horner syndrome in pediatric patientsBACAL, Darron A; LEVY, Susan R.Archives of ophthalmology (1960). 2004, Vol 122, Num 2, pp 276-279, issn 0003-9950, 4 p.Article